221 related articles for article (PubMed ID: 33989753)
1. Formulation of ionic liquid APIs via spray drying processes to enable conversion into single and two-phase solid forms.
Tsolaki E; Stocker MW; Healy AM; Ferguson S
Int J Pharm; 2021 Jun; 603():120669. PubMed ID: 33989753
[TBL] [Abstract][Full Text] [Related]
2. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
Stocker MW; Healy AM; Ferguson S
Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
[TBL] [Abstract][Full Text] [Related]
3. Combining Isolation-Free and Co-Processing Manufacturing Approaches to Access Room Temperature Ionic Liquid Forms of APIs.
Stocker MW; Tsolaki E; Harding MJ; Healy AM; Ferguson S
J Pharm Sci; 2023 Aug; 112(8):2079-2086. PubMed ID: 36806585
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin.
Myślińska M; Stocker MW; Ferguson S; Healy AM
J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392
[TBL] [Abstract][Full Text] [Related]
5. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
6. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Spray Drying and Co-Precipitation as Manufacturing Processes for Amorphous Solid Dispersions of a Low T
Solomos MA; Punia A; Saboo S; John C; Boyce CW; Chin A; Taggart RV; Smith D; Lamm MS; Schenck L
J Pharm Sci; 2023 Aug; 112(8):2087-2096. PubMed ID: 36822272
[TBL] [Abstract][Full Text] [Related]
9. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
11. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
12. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
[TBL] [Abstract][Full Text] [Related]
13. Gaining Insight into the Role of the Solvent during Spray Drying of Amorphous Solid Dispersions by Studying Evaporation Kinetics.
Dedroog S; Adriaensens P; Van den Mooter G
Mol Pharm; 2022 May; 19(5):1604-1618. PubMed ID: 35362988
[TBL] [Abstract][Full Text] [Related]
14. Correlationship of Drug-Polymer Miscibility, Molecular Relaxation and Phase Behavior of Dipyridamole Amorphous Solid Dispersions.
Sharma J; Singh B; Agrawal AK; Bansal AK
J Pharm Sci; 2021 Apr; 110(4):1470-1479. PubMed ID: 33333143
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
[TBL] [Abstract][Full Text] [Related]
16. Ionic liquids in drug delivery.
Shamshina JL; Barber PS; Rogers RD
Expert Opin Drug Deliv; 2013 Oct; 10(10):1367-81. PubMed ID: 23795613
[TBL] [Abstract][Full Text] [Related]
17.
Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
[TBL] [Abstract][Full Text] [Related]
18. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance.
Pugliese A; Tobyn M; Hawarden LE; Abraham A; Blanc F
Mol Pharm; 2022 Nov; 19(11):3685-3699. PubMed ID: 36037249
[TBL] [Abstract][Full Text] [Related]
19. Transformation of acidic poorly water soluble drugs into ionic liquids.
Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
[TBL] [Abstract][Full Text] [Related]
20. Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review.
Yu DG; Li JJ; Williams GR; Zhao M
J Control Release; 2018 Dec; 292():91-110. PubMed ID: 30118788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
